---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-25-000118"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:39:45.167100+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04

## Summary
- Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.
- Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.
- Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter.

## SEC filing metadata
- accession: 0001729149-25-000118
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/0001729149-25-000118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/vmd-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-25-000118
- JSON: https://secwatch.observer/filing/0001729149-25-000118.json
- Plain text: https://secwatch.observer/filing/0001729149-25-000118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.